Med BioGene Extends Lung Cancer Biomarker Deal with UHN | GenomeWeb

NEW YORK (GenomeWeb News) – Med BioGene has extended its biomarker collaboration with the University Health Network in Toronto.

The deal expands the firm's previous exclusive license and collaboration with UHN, which will provide additional novel gene expression-based markers for its early-stage non-small cell lung cancer test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.